Quantbot Technologies LP Keros Therapeutics, Inc. Transaction History
Quantbot Technologies LP
- $2.88 Billion
- Q1 2025
A detailed history of Quantbot Technologies LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 386 shares of KROS stock, worth $5,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
386
Previous 380
1.58%
Holding current value
$5,172
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KROS
# of Institutions
176Shares Held
36.5MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$52.9 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$34.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$33.7 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$26.8 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $345M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...